1. Home
  2. BHVN vs AOD Comparison

BHVN vs AOD Comparison

Compare BHVN & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$10.54

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo abrdn Total Dynamic Dividend Fund of Beneficial Interest

AOD

abrdn Total Dynamic Dividend Fund of Beneficial Interest

HOLD

Current Price

$9.66

Market Cap

970.0M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
BHVN
AOD
Founded
2013
2006
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
970.0M
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
BHVN
AOD
Price
$10.54
$9.66
Analyst Decision
Buy
Analyst Count
16
0
Target Price
$29.79
N/A
AVG Volume (30 Days)
4.4M
423.5K
Earning Date
11-10-2025
01-01-0001
Dividend Yield
N/A
12.95%
EPS Growth
N/A
213.63
EPS
N/A
1.93
Revenue
N/A
$72,962,082.00
Revenue This Year
N/A
N/A
Revenue Next Year
$2,219.74
N/A
P/E Ratio
N/A
$4.44
Revenue Growth
N/A
N/A
52 Week Low
$7.48
$6.99
52 Week High
$45.87
$9.14

Technical Indicators

Market Signals
Indicator
BHVN
AOD
Relative Strength Index (RSI) 49.90 60.20
Support Level $8.29 $9.57
Resistance Level $10.18 $9.74
Average True Range (ATR) 0.76 0.10
MACD 0.34 0.03
Stochastic Oscillator 90.59 85.59

Price Performance

Historical Comparison
BHVN
AOD

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest

Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.

Share on Social Networks: